img

Global Hepatitis B Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hepatitis B Drug Market Insights, Forecast to 2034

Treatment for chronic hepatitis B may includeAntiviral medications. Several antiviral medications — including entecavir (Baraclude), tenofovir (Viread), lamivudine (Epivir), adefovir (Hepsera) and telbivudine (Tyzeka) — can help fight the virus and slow its ability to damage your liver.
Market Analysis and InsightsGlobal Hepatitis B Drug Market
Global Hepatitis B Drug market is expected to reach to US$ 2286 million in 2024, with a positive growth of %, compared with US$ 2157 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Hepatitis B Drug industry is evaluated to reach US$ 3242.7 million in 2029. The CAGR will be 6.0% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Hepatitis B Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Hepatitis B Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithKline
Bristol-Myers Squibb
Mitsubishi Tanabe Pharma
Johnson & Johnson
Roche
Gilead Sciences
Merck & Co. Inc.
Novartis
AbbVie
Segment by Type
Entecavir
Tenofovir
Lamivudine
Adefovir
Telbivudine
Others

Segment by Application


Hospital Pharmacies
Retail Pharmacies & Drug Stores
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Hepatitis B Drug introduction, etc. Hepatitis B Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Hepatitis B Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis B Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Entecavir
1.2.3 Tenofovir
1.2.4 Lamivudine
1.2.5 Adefovir
1.2.6 Telbivudine
1.2.7 Others
1.3 Market by Application
1.3.1 Global Hepatitis B Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies & Drug Stores
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hepatitis B Drug Market Perspective (2018-2029)
2.2 Global Hepatitis B Drug Growth Trends by Region
2.2.1 Hepatitis B Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hepatitis B Drug Historic Market Size by Region (2018-2024)
2.2.3 Hepatitis B Drug Forecasted Market Size by Region (2024-2029)
2.3 Hepatitis B Drug Market Dynamics
2.3.1 Hepatitis B Drug Industry Trends
2.3.2 Hepatitis B Drug Market Drivers
2.3.3 Hepatitis B Drug Market Challenges
2.3.4 Hepatitis B Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Hepatitis B Drug by Players
3.1.1 Global Hepatitis B Drug Revenue by Players (2018-2024)
3.1.2 Global Hepatitis B Drug Revenue Market Share by Players (2018-2024)
3.2 Global Hepatitis B Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Hepatitis B Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Hepatitis B Drug Market Concentration Ratio
3.4.1 Global Hepatitis B Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis B Drug Revenue in 2022
3.5 Global Key Players of Hepatitis B Drug Head office and Area Served
3.6 Global Key Players of Hepatitis B Drug, Product and Application
3.7 Global Key Players of Hepatitis B Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatitis B Drug Breakdown Data by Type
4.1 Global Hepatitis B Drug Historic Market Size by Type (2018-2024)
4.2 Global Hepatitis B Drug Forecasted Market Size by Type (2024-2029)
5 Hepatitis B Drug Breakdown Data by Application
5.1 Global Hepatitis B Drug Historic Market Size by Application (2018-2024)
5.2 Global Hepatitis B Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Hepatitis B Drug Market Size (2018-2029)
6.2 North America Hepatitis B Drug Market Size by Type
6.2.1 North America Hepatitis B Drug Market Size by Type (2018-2024)
6.2.2 North America Hepatitis B Drug Market Size by Type (2024-2029)
6.2.3 North America Hepatitis B Drug Market Share by Type (2018-2029)
6.3 North America Hepatitis B Drug Market Size by Application
6.3.1 North America Hepatitis B Drug Market Size by Application (2018-2024)
6.3.2 North America Hepatitis B Drug Market Size by Application (2024-2029)
6.3.3 North America Hepatitis B Drug Market Share by Application (2018-2029)
6.4 North America Hepatitis B Drug Market Size by Country
6.4.1 North America Hepatitis B Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Hepatitis B Drug Market Size by Country (2018-2024)
6.4.3 North America Hepatitis B Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Hepatitis B Drug Market Size (2018-2029)
7.2 Europe Hepatitis B Drug Market Size by Type
7.2.1 Europe Hepatitis B Drug Market Size by Type (2018-2024)
7.2.2 Europe Hepatitis B Drug Market Size by Type (2024-2029)
7.2.3 Europe Hepatitis B Drug Market Share by Type (2018-2029)
7.3 Europe Hepatitis B Drug Market Size by Application
7.3.1 Europe Hepatitis B Drug Market Size by Application (2018-2024)
7.3.2 Europe Hepatitis B Drug Market Size by Application (2024-2029)
7.3.3 Europe Hepatitis B Drug Market Share by Application (2018-2029)
7.4 Europe Hepatitis B Drug Market Size by Country
7.4.1 Europe Hepatitis B Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Hepatitis B Drug Market Size by Country (2018-2024)
7.4.3 Europe Hepatitis B Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Hepatitis B Drug Market Size (2018-2029)
8.2 China Hepatitis B Drug Market Size by Type
8.2.1 China Hepatitis B Drug Market Size by Type (2018-2024)
8.2.2 China Hepatitis B Drug Market Size by Type (2024-2029)
8.2.3 China Hepatitis B Drug Market Share by Type (2018-2029)
8.3 China Hepatitis B Drug Market Size by Application
8.3.1 China Hepatitis B Drug Market Size by Application (2018-2024)
8.3.2 China Hepatitis B Drug Market Size by Application (2024-2029)
8.3.3 China Hepatitis B Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Hepatitis B Drug Market Size (2018-2029)
9.2 Asia Hepatitis B Drug Market Size by Type
9.2.1 Asia Hepatitis B Drug Market Size by Type (2018-2024)
9.2.2 Asia Hepatitis B Drug Market Size by Type (2024-2029)
9.2.3 Asia Hepatitis B Drug Market Share by Type (2018-2029)
9.3 Asia Hepatitis B Drug Market Size by Application
9.3.1 Asia Hepatitis B Drug Market Size by Application (2018-2024)
9.3.2 Asia Hepatitis B Drug Market Size by Application (2024-2029)
9.3.3 Asia Hepatitis B Drug Market Share by Application (2018-2029)
9.4 Asia Hepatitis B Drug Market Size by Region
9.4.1 Asia Hepatitis B Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Hepatitis B Drug Market Size by Region (2018-2024)
9.4.3 Asia Hepatitis B Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Hepatitis B Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Hepatitis B Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Hepatitis B Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Hepatitis B Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Hepatitis B Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Hepatitis B Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Hepatitis B Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Hepatitis B Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Hepatitis B Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Hepatitis B Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Hepatitis B Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Hepatitis B Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Hepatitis B Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Hepatitis B Drug Introduction
11.1.4 GlaxoSmithKline Revenue in Hepatitis B Drug Business (2018-2024)
11.1.5 GlaxoSmithKline Recent Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Hepatitis B Drug Introduction
11.2.4 Bristol-Myers Squibb Revenue in Hepatitis B Drug Business (2018-2024)
11.2.5 Bristol-Myers Squibb Recent Developments
11.3 Mitsubishi Tanabe Pharma
11.3.1 Mitsubishi Tanabe Pharma Company Details
11.3.2 Mitsubishi Tanabe Pharma Business Overview
11.3.3 Mitsubishi Tanabe Pharma Hepatitis B Drug Introduction
11.3.4 Mitsubishi Tanabe Pharma Revenue in Hepatitis B Drug Business (2018-2024)
11.3.5 Mitsubishi Tanabe Pharma Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Hepatitis B Drug Introduction
11.4.4 Johnson & Johnson Revenue in Hepatitis B Drug Business (2018-2024)
11.4.5 Johnson & Johnson Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Hepatitis B Drug Introduction
11.5.4 Roche Revenue in Hepatitis B Drug Business (2018-2024)
11.5.5 Roche Recent Developments
11.6 Gilead Sciences
11.6.1 Gilead Sciences Company Details
11.6.2 Gilead Sciences Business Overview
11.6.3 Gilead Sciences Hepatitis B Drug Introduction
11.6.4 Gilead Sciences Revenue in Hepatitis B Drug Business (2018-2024)
11.6.5 Gilead Sciences Recent Developments
11.7 Merck & Co. Inc.
11.7.1 Merck & Co. Inc. Company Details
11.7.2 Merck & Co. Inc. Business Overview
11.7.3 Merck & Co. Inc. Hepatitis B Drug Introduction
11.7.4 Merck & Co. Inc. Revenue in Hepatitis B Drug Business (2018-2024)
11.7.5 Merck & Co. Inc. Recent Developments
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Hepatitis B Drug Introduction
11.8.4 Novartis Revenue in Hepatitis B Drug Business (2018-2024)
11.8.5 Novartis Recent Developments
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Hepatitis B Drug Introduction
11.9.4 AbbVie Revenue in Hepatitis B Drug Business (2018-2024)
11.9.5 AbbVie Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Hepatitis B Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Entecavir
Table 3. Key Players of Tenofovir
Table 4. Key Players of Lamivudine
Table 5. Key Players of Adefovir
Table 6. Key Players of Telbivudine
Table 7. Key Players of Others
Table 8. Global Hepatitis B Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 9. Global Hepatitis B Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 10. Global Hepatitis B Drug Market Size by Region (2018-2024) & (US$ Million)
Table 11. Global Hepatitis B Drug Market Share by Region (2018-2024)
Table 12. Global Hepatitis B Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 13. Global Hepatitis B Drug Market Share by Region (2024-2029)
Table 14. Hepatitis B Drug Market Trends
Table 15. Hepatitis B Drug Market Drivers
Table 16. Hepatitis B Drug Market Challenges
Table 17. Hepatitis B Drug Market Restraints
Table 18. Global Hepatitis B Drug Revenue by Players (2018-2024) & (US$ Million)
Table 19. Global Hepatitis B Drug Revenue Share by Players (2018-2024)
Table 20. Global Top Hepatitis B Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Drug as of 2022)
Table 21. Global Hepatitis B Drug Industry Ranking 2021 VS 2022 VS 2024
Table 22. Global 5 Largest Players Market Share by Hepatitis B Drug Revenue (CR5 and HHI) & (2018-2024)
Table 23. Global Key Players of Hepatitis B Drug, Headquarters and Area Served
Table 24. Global Key Players of Hepatitis B Drug, Product and Application
Table 25. Global Key Players of Hepatitis B Drug, Product and Application
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hepatitis B Drug Market Size by Type (2018-2024) & (US$ Million)
Table 28. Global Hepatitis B Drug Revenue Market Share by Type (2018-2024)
Table 29. Global Hepatitis B Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 30. Global Hepatitis B Drug Revenue Market Share by Type (2024-2029)
Table 31. Global Hepatitis B Drug Market Size by Application (2018-2024) & (US$ Million)
Table 32. Global Hepatitis B Drug Revenue Share by Application (2018-2024)
Table 33. Global Hepatitis B Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 34. Global Hepatitis B Drug Revenue Share by Application (2024-2029)
Table 35. North America Hepatitis B Drug Market Size by Type (2018-2024) & (US$ Million)
Table 36. North America Hepatitis B Drug Market Size by Type (2024-2029) & (US$ Million)
Table 37. North America Hepatitis B Drug Market Size by Application (2018-2024) & (US$ Million)
Table 38. North America Hepatitis B Drug Market Size by Application (2024-2029) & (US$ Million)
Table 39. North America Hepatitis B Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 40. North America Hepatitis B Drug Market Size by Country (2018-2024) & (US$ Million)
Table 41. North America Hepatitis B Drug Market Size by Country (2024-2029) & (US$ Million)
Table 42. Europe Hepatitis B Drug Market Size by Type (2018-2024) & (US$ Million)
Table 43. Europe Hepatitis B Drug Market Size by Type (2024-2029) & (US$ Million)
Table 44. Europe Hepatitis B Drug Market Size by Application (2018-2024) & (US$ Million)
Table 45. Europe Hepatitis B Drug Market Size by Application (2024-2029) & (US$ Million)
Table 46. Europe Hepatitis B Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Europe Hepatitis B Drug Market Size by Country (2018-2024) & (US$ Million)
Table 48. Europe Hepatitis B Drug Market Size by Country (2024-2029) & (US$ Million)
Table 49. China Hepatitis B Drug Market Size by Type (2018-2024) & (US$ Million)
Table 50. China Hepatitis B Drug Market Size by Type (2024-2029) & (US$ Million)
Table 51. China Hepatitis B Drug Market Size by Application (2018-2024) & (US$ Million)
Table 52. China Hepatitis B Drug Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Hepatitis B Drug Market Size by Type (2018-2024) & (US$ Million)
Table 54. Asia Hepatitis B Drug Market Size by Type (2024-2029) & (US$ Million)
Table 55. Asia Hepatitis B Drug Market Size by Application (2018-2024) & (US$ Million)
Table 56. Asia Hepatitis B Drug Market Size by Application (2024-2029) & (US$ Million)
Table 57. Asia Hepatitis B Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 58. Asia Hepatitis B Drug Market Size by Region (2018-2024) & (US$ Million)
Table 59. Asia Hepatitis B Drug Market Size by Region (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Hepatitis B Drug Market Size by Type (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Hepatitis B Drug Market Size by Type (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Hepatitis B Drug Market Size by Application (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Hepatitis B Drug Market Size by Application (2024-2029) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Hepatitis B Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 65. Middle East, Africa, and Latin America Hepatitis B Drug Market Size by Country (2018-2024) & (US$ Million)
Table 66. Middle East, Africa, and Latin America Hepatitis B Drug Market Size by Country (2024-2029) & (US$ Million)
Table 67. GlaxoSmithKline Company Details
Table 68. GlaxoSmithKline Business Overview
Table 69. GlaxoSmithKline Hepatitis B Drug Product
Table 70. GlaxoSmithKline Revenue in Hepatitis B Drug Business (2018-2024) & (US$ Million)
Table 71. GlaxoSmithKline Recent Developments
Table 72. Bristol-Myers Squibb Company Details
Table 73. Bristol-Myers Squibb Business Overview
Table 74. Bristol-Myers Squibb Hepatitis B Drug Product
Table 75. Bristol-Myers Squibb Revenue in Hepatitis B Drug Business (2018-2024) & (US$ Million)
Table 76. Bristol-Myers Squibb Recent Developments
Table 77. Mitsubishi Tanabe Pharma Company Details
Table 78. Mitsubishi Tanabe Pharma Business Overview
Table 79. Mitsubishi Tanabe Pharma Hepatitis B Drug Product
Table 80. Mitsubishi Tanabe Pharma Revenue in Hepatitis B Drug Business (2018-2024) & (US$ Million)
Table 81. Mitsubishi Tanabe Pharma Recent Developments
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Hepatitis B Drug Product
Table 85. Johnson & Johnson Revenue in Hepatitis B Drug Business (2018-2024) & (US$ Million)
Table 86. Johnson & Johnson Recent Developments
Table 87. Roche Company Details
Table 88. Roche Business Overview
Table 89. Roche Hepatitis B Drug Product
Table 90. Roche Revenue in Hepatitis B Drug Business (2018-2024) & (US$ Million)
Table 91. Roche Recent Developments
Table 92. Gilead Sciences Company Details
Table 93. Gilead Sciences Business Overview
Table 94. Gilead Sciences Hepatitis B Drug Product
Table 95. Gilead Sciences Revenue in Hepatitis B Drug Business (2018-2024) & (US$ Million)
Table 96. Gilead Sciences Recent Developments
Table 97. Merck & Co. Inc. Company Details
Table 98. Merck & Co. Inc. Business Overview
Table 99. Merck & Co. Inc. Hepatitis B Drug Product
Table 100. Merck & Co. Inc. Revenue in Hepatitis B Drug Business (2018-2024) & (US$ Million)
Table 101. Merck & Co. Inc. Recent Developments
Table 102. Novartis Company Details
Table 103. Novartis Business Overview
Table 104. Novartis Hepatitis B Drug Product
Table 105. Novartis Revenue in Hepatitis B Drug Business (2018-2024) & (US$ Million)
Table 106. Novartis Recent Developments
Table 107. AbbVie Company Details
Table 108. AbbVie Business Overview
Table 109. AbbVie Hepatitis B Drug Product
Table 110. AbbVie Revenue in Hepatitis B Drug Business (2018-2024) & (US$ Million)
Table 111. AbbVie Recent Developments
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis B Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Hepatitis B Drug Market Share by Type: 2022 VS 2029
Figure 3. Entecavir Features
Figure 4. Tenofovir Features
Figure 5. Lamivudine Features
Figure 6. Adefovir Features
Figure 7. Telbivudine Features
Figure 8. Others Features
Figure 9. Global Hepatitis B Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Hepatitis B Drug Market Share by Application: 2022 VS 2029
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail Pharmacies & Drug Stores Case Studies
Figure 13. Others Case Studies
Figure 14. Hepatitis B Drug Report Years Considered
Figure 15. Global Hepatitis B Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Hepatitis B Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Hepatitis B Drug Market Share by Region: 2022 VS 2029
Figure 18. Global Hepatitis B Drug Market Share by Players in 2022
Figure 19. Global Top Hepatitis B Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Drug as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Hepatitis B Drug Revenue in 2022
Figure 21. North America Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Hepatitis B Drug Market Share by Type (2018-2029)
Figure 23. North America Hepatitis B Drug Market Share by Application (2018-2029)
Figure 24. North America Hepatitis B Drug Market Share by Country (2018-2029)
Figure 25. United States Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Hepatitis B Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Hepatitis B Drug Market Share by Type (2018-2029)
Figure 29. Europe Hepatitis B Drug Market Share by Application (2018-2029)
Figure 30. Europe Hepatitis B Drug Market Share by Country (2018-2029)
Figure 31. Germany Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Hepatitis B Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Hepatitis B Drug Market Share by Type (2018-2029)
Figure 39. China Hepatitis B Drug Market Share by Application (2018-2029)
Figure 40. Asia Hepatitis B Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Hepatitis B Drug Market Share by Type (2018-2029)
Figure 42. Asia Hepatitis B Drug Market Share by Application (2018-2029)
Figure 43. Asia Hepatitis B Drug Market Share by Region (2018-2029)
Figure 44. Japan Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Hepatitis B Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Hepatitis B Drug Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Hepatitis B Drug Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Hepatitis B Drug Market Share by Country (2018-2029)
Figure 54. Brazil Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Hepatitis B Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Hepatitis B Drug Business (2018-2024)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis B Drug Business (2018-2024)
Figure 62. Mitsubishi Tanabe Pharma Revenue Growth Rate in Hepatitis B Drug Business (2018-2024)
Figure 63. Johnson & Johnson Revenue Growth Rate in Hepatitis B Drug Business (2018-2024)
Figure 64. Roche Revenue Growth Rate in Hepatitis B Drug Business (2018-2024)
Figure 65. Gilead Sciences Revenue Growth Rate in Hepatitis B Drug Business (2018-2024)
Figure 66. Merck & Co. Inc. Revenue Growth Rate in Hepatitis B Drug Business (2018-2024)
Figure 67. Novartis Revenue Growth Rate in Hepatitis B Drug Business (2018-2024)
Figure 68. AbbVie Revenue Growth Rate in Hepatitis B Drug Business (2018-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries